| Autor: |
Kelly McCarter, M.D., Joshua Stewart, M.D., Sushmita Gordhandas, M.D., Ashley Aluko, M.D., Nirali Shah, M.D., Glenn Schattman, M.D., Zev Rosenwaks, M.D. |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
F&S Reports, Vol 3, Iss 4, Pp 349-354 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2666-3341 |
| DOI: |
10.1016/j.xfre.2022.08.001 |
| Popis: |
Objective: To analyze the use of services regarding fertility preservation (FP) in cancer patients at a single institution. Design: A retrospective cohort study. Setting: Academic medical center. Patient(s): A total of 208 FP referrals. Intervention(s): None. Main Outcome Measure(s): Method of FP; time from referral to FP intervention. Result(s): A total of 553 patients were referred to a reproductive specialist for FP in the setting of a medical diagnosis from 2011 to 2016. Of these, 208 patients satisfied the inclusion criteria and met with a reproductive specialist. Ninety patients underwent FP services. The average age at referral was 30.9 ± 7.9 years. Breast cancer (n=94, 45%) and leukemia/lymphoma (n=62, 30%) were the most prevalent cancer diagnoses. A 68.9% of patients underwent oocyte cryopreservation (n=62), 26.7% underwent embryo cryopreservation (n=24) and 4.4% underwent ovarian tissue preservation (n=4). The time interval from the referral to the FP intervention ranged from 1 to 810 days, with a median of 17 days. Conclusion(s): In the setting of a cancer diagnosis, most patients undergoing FP intervention underwent oocyte cryopreservation, were |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
